Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118221 · ClinicalTrials.gov registry record · NA
Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01118221 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 25 participants.
The verdict
NCT01118221, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The incidence and prevalence of IPF increase exponentially with age, and IPF occurs more often in older males. Cigarette smoking and environmental dust exposures are known risk factors for developing IPF. For example, the recently deployed military population, as it ages, is at especially increased risk of IPF. No effective therapies exist, although lung transplantation is used to extend survival of selected patients. Defining specific therapy to improve exercise tolerance and dyspnea in IPF patients is thus an urgent priority of veteran-oriented research programs.
Interventions
- BEHAVIORAL pulmonary rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01118221
The ClinicalTrials.gov registry entry for NCT01118221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pulmonary rehabilitation is the first listed.
NCT01118221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01118221 about?
NCT01118221 is a clinical study titled "Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients". The incidence and prevalence of IPF increase exponentially with age, and IPF occurs more often in older males. Cigarette smoking and environmental dust exposures are known risk factors for developing IPF. For example, the recently deployed military population, as it ages, is at especially increased ...
What is the current status of trial NCT01118221?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2010-10. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01118221?
The interventions under investigation include: pulmonary rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01118221?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.